CONMED Corporation
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $55.5M | $14.7M | $30.5M | $32.2M | $35.9M | $40.5M | $752.0K | $30.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $20.1M | $20.5M | $18.7M | $19.8M | $18.7M | $18.6M | $18.5M | $17.4M |
| Amortization | $21.3M | $20.0M | $12.6M | $13.0M | $13.7M | $13.8M | $6.5M | — |
| Stock-Based Compensation | $8.5M | $8.4M | $7.5M | $9.3M | $5.6M | $5.7M | $5.2M | $4.2M |
| Net Cash from Operating Activities | $65.6M | $39.9M | $50.9M | $65.2M | $80.9M | $95.2M | $103.0M | $38.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $12.8M | $14.8M | $15.0M | $15.4M | $18.4M | $21.5M | $17.6M | $14.7M |
| Business Acquisitions | — | — | $6.1M | — | — | — | — | — |
| Net Cash from Investing Activities | $-29.1M | $-266.0M | $-24.4M | $-20.7M | $-18.4M | $-105.9M | $-21.7M | $-20.0M |
| Financing Activities | ||||||||
| Dividends Paid | $22.3M | $22.2M | $22.1M | $22.0M | $16.7M | $12.9M | $0 | $0 |
| Stock Repurchases | — | $0 | $0 | $16.9M | $50.6M | $3.9M | $15.0M | $23.0M |
| Net Cash from Financing Activities | $-34.9M | $182.5M | $-12.6M | $-26.4M | $-31.3M | $11.4M | $-66.7M | $-15.6M |
| Net Change in Cash | $5.2M | $-45.1M | $6.2M | $11.9M | $30.7M | $-2.3M | $13.6M | $2.3M |
| Free Cash Flow | $52.7M | $25.1M | $35.9M | $49.8M | $62.5M | $73.7M | $85.4M | $23.5M |